Boston Scientific (BSX) Q2 Earnings Beat, Organic Sales Rise

Boston Scientific Corporation (BSX) posted adjusted earnings per share (EPS) of 62 cents for the second quarter of 2024, up 16.9% from the year-ago figure. The figure beat the Zacks Consensus Estimate by 6.9% and also exceeded the company’s adjusted earnings per share guidance range of 57-59 cents per share.The quarter’s adjustments included certain intangible asset impairment charges, amortization expenses, acquisition/divestitures-related net charges, and restructuring and restructuring-related charges, a ...